• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p57kip2、Rb蛋白和增殖细胞核抗原在人胰腺癌中的表达及其与临床病理的关系。

Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.

作者信息

Yue Hui, Na Yan-Li, Feng Xin-Li, Ma Shu-Ren, Song Fu-Lin, Yang Bo

机构信息

Department of Gastroenterology, General Hospital of Shenyang Military Region, Shenyang 110016, Liaoning Province, China.

出版信息

World J Gastroenterol. 2003 Feb;9(2):377-80. doi: 10.3748/wjg.v9.i2.377.

DOI:10.3748/wjg.v9.i2.377
PMID:12532471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4611351/
Abstract

AIM

To investigate the effects of inhibiting factor of cell cycle regulation p57(kip2), retinoblastinoma protein (Rb protein) and proliferating cell nuclear antigen (PCNA) in the genesis and progression of human pancreatic cancer.

METHODS

The expression of p57(kip2), Rb protein and PCNA in tumor tissues and adjacent tissues of 32 patients with pancreatic cancer was detected with SP immunohistochemical technique.

RESULTS

p57(kip2) protein positive-expression rate in tumor tissues of pancreatic cancer was 46.9 %, which was lower than that in adjacent pancreatic tissues (75.0 %) (chi(2)=5.317, P<0.05), p57(kip2) protein positive-expression correlated significantly with tumor cell differentiation (well-differentiation versus moderate or low-differentiation, P<0.05) but did not correlate significantly with lymph node metastasis (lymph node metastasis versus non-lymph node metastasis, P>0.05); Rb gene protein positive-expression rate in tumor tissues was 50.0 %, which was also lower than that in adjacent pancreatic tissues (78.1 %) (chi(2)=5.497, P<0.05); PCNA positive-expression rate was 71.9 %, being higher than that in adjacent pancreatic tissues (43.8 %) (chi(2)=5.189, P<0.05), PCNA positive-expression also correlated significantly with tumor cell differentiation and lymph node metastasis (well-differentiation versus moderate or low- differentiation, lymph node metastasis versus non-lymph node metastasis, P<0.05). Rb protein positive-expression rate in the tumor tissues of p57(kip2) protein positive-expression group was 53.3 %; and Rb protein positive-expression rate in the tumor tissues of p57(kip2) protein negative-expression group was 47.1 %. There was no significant relationship between the two groups (r=0.16507, P>0.05).

CONCLUSION

The decreased expression of p57(kip2), Rb protein or over-expression of PCNA protein might contribute to the genesis or progression of pancreatic cancer, p57(kip2), Rb protein and PCNA may play an important role in genesis and progression of pancreatic cancer.

摘要

目的

探讨细胞周期调控抑制因子p57(kip2)、视网膜母细胞瘤蛋白(Rb蛋白)和增殖细胞核抗原(PCNA)在人胰腺癌发生发展中的作用。

方法

采用SP免疫组化技术检测32例胰腺癌患者肿瘤组织及癌旁组织中p57(kip2)、Rb蛋白和PCNA的表达。

结果

胰腺癌肿瘤组织中p57(kip2)蛋白阳性表达率为46.9%,低于癌旁胰腺组织(75.0%)(χ2=5.317,P<0.05),p57(kip2)蛋白阳性表达与肿瘤细胞分化显著相关(高分化与中低分化比较,P<0.05),但与淋巴结转移无显著相关性(有淋巴结转移与无淋巴结转移比较,P>0.05);肿瘤组织中Rb基因蛋白阳性表达率为50.0%,也低于癌旁胰腺组织(78.1%)(χ2=5.497,P<0.05);PCNA阳性表达率为71.9%,高于癌旁胰腺组织(43.8%)(χ2=5.189,P<0.05),PCNA阳性表达也与肿瘤细胞分化及淋巴结转移显著相关(高分化与中低分化比较,有淋巴结转移与无淋巴结转移比较,P<0.05)。p57(kip2)蛋白阳性表达组肿瘤组织中Rb蛋白阳性表达率为53.3%;p57(kip2)蛋白阴性表达组肿瘤组织中Rb蛋白阳性表达率为为47.1%。两组间无显著相关性(r=0.16507,P>0.05)。

结论

p57(kip2)、Rb蛋白表达降低或PCNA蛋白过表达可能与胰腺癌的发生发展有关,p57(kip2)、Rb蛋白和PCNA可能在胰腺癌的发生发展中起重要作用。

相似文献

1
Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.p57kip2、Rb蛋白和增殖细胞核抗原在人胰腺癌中的表达及其与临床病理的关系。
World J Gastroenterol. 2003 Feb;9(2):377-80. doi: 10.3748/wjg.v9.i2.377.
2
Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.细胞周期调节因子p57kip2、细胞周期蛋白E蛋白及增殖细胞核抗原在人胰腺癌中的表达:一项免疫组织化学研究
World J Gastroenterol. 2005 Aug 28;11(32):5057-60. doi: 10.3748/wjg.v11.i32.5057.
3
[Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].[人胰腺癌中p57(kip2)、细胞周期蛋白E蛋白、增殖细胞核抗原的表达与临床病理因素的关系]
Ai Zheng. 2003 Jul;22(7):705-9.
4
Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.P57(kip2)和细胞周期蛋白E蛋白在人胰腺癌中的表达
Chin Med J (Engl). 2003 Jun;116(6):944-6.
5
Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.原发性肝癌中p57(kip2)的表达及其与临床病理、增殖细胞核抗原和p53的关系
World J Gastroenterol. 2005 Feb 28;11(8):1237-40. doi: 10.3748/wjg.v11.i8.1237.
6
Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer.p27(kip1)、Rb蛋白和增殖细胞核抗原在人胰腺癌中的表达及其与临床病理的关系
Hepatobiliary Pancreat Dis Int. 2003 Feb;2(1):142-6.
7
Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.p57(KIP2)在肝细胞癌中的表达:肿瘤分化与患者生存之间的关系。
Int J Oncol. 2002 Apr;20(4):769-75.
8
Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.细胞周期蛋白E、细胞周期蛋白依赖性激酶2和p57(KIP2)在人胃癌中的表达
Chin Med J (Engl). 2003 Jan;116(1):20-3.
9
The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.细胞周期蛋白激酶抑制剂p57kip2调节转化生长因子β诱导的代偿性肾小管肥大:免疫调节剂AS101的作用
Nephrol Dial Transplant. 2009 Aug;24(8):2328-38. doi: 10.1093/ndt/gfn742. Epub 2009 Mar 25.
10
Expression of p57/Kip2 protein in pancreatic adenocarcinoma.p57/Kip2蛋白在胰腺腺癌中的表达。
Pancreas. 2001 Oct;23(3):246-50. doi: 10.1097/00006676-200110000-00004.

引用本文的文献

1
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review.增殖标志物在胰腺癌治疗中的潜力:一项系统评价。
Health Sci Rep. 2025 Mar 5;8(3):e70412. doi: 10.1002/hsr2.70412. eCollection 2025 Mar.
2
Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer.将 SET 和 MYND 结构域蛋白 2 的机制和功能外推至胰腺癌。
World J Gastroenterol. 2022 Aug 7;28(29):3753-3766. doi: 10.3748/wjg.v28.i29.3753.
3
Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.应用特定的自动化细胞图像分析系统检测结直肠腺瘤和癌中 PCNA 和 CD34 的免疫组化表达:一项临床病理研究。
Saudi J Gastroenterol. 2012 Jul-Aug;18(4):268-76. doi: 10.4103/1319-3767.98435.
4
In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.利用氢质子磁共振波谱对星形细胞瘤细胞增殖进行的体内研究:与组织病理学及免疫组织化学的相关性
Neuroradiology. 2006 May;48(5):312-8. doi: 10.1007/s00234-006-0066-3. Epub 2006 Mar 22.
5
Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.原发性肝癌中p57(kip2)的表达及其与临床病理、增殖细胞核抗原和p53的关系
World J Gastroenterol. 2005 Feb 28;11(8):1237-40. doi: 10.3748/wjg.v11.i8.1237.
6
Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance.维生素E琥珀酸酯对人胃癌细胞中Fas和PCNA蛋白表达的影响及其临床意义
World J Gastroenterol. 2004 Apr 1;10(7):945-9. doi: 10.3748/wjg.v10.i7.945.
7
Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro.大豆苷元对雌激素受体阳性和阴性胰腺癌细胞的体外作用。
World J Gastroenterol. 2004 Mar 15;10(6):860-3. doi: 10.3748/wjg.v10.i6.860.
8
Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis.增殖细胞核抗原(PCNA)和CD44mRNA在伴静脉侵犯的结直肠癌中的表达及其与肝转移的关系
World J Gastroenterol. 2003 Dec;9(12):2863-5. doi: 10.3748/wjg.v9.i12.2863.
9
Gene-expression analysis of single cells-nested polymerase chain reaction after laser microdissection.激光显微切割后单细胞基因表达分析——巢式聚合酶链反应
World J Gastroenterol. 2003 Jun;9(6):1337-41. doi: 10.3748/wjg.v9.i6.1337.

本文引用的文献

1
Molecular pathogenesis of pancreatic cancer.胰腺癌的分子发病机制
Hematol Oncol Clin North Am. 2002 Feb;16(1):17-35, v. doi: 10.1016/s0889-8588(01)00005-3.
2
Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China.中国北方高发区贲门癌前病变中抑癌基因p16和Rb的表达
World J Gastroenterol. 2002 Jun;8(3):423-5. doi: 10.3748/wjg.v8.i3.423.
3
Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.p57/Kip2蛋白在肝外胆管癌和肝内胆管细胞癌中的表达
Liver. 2002 Apr;22(2):145-9. doi: 10.1034/j.1600-0676.2002.01532.x.
4
Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.胰腺导管内乳头状黏液性肿瘤中环氧合酶-2表达的免疫组织化学分析及原位杂交
Cancer. 2002 Mar 1;94(5):1565-73. doi: 10.1002/cncr.10358.
5
[Gene therapy for pancreatic cancer].[胰腺癌的基因治疗]
Gan To Kagaku Ryoho. 2002 Mar;29(3):398-404.
6
Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.p57(KIP2)在肝细胞癌中的表达:肿瘤分化与患者生存之间的关系。
Int J Oncol. 2002 Apr;20(4):769-75.
7
Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.p57/Kip2蛋白在正常及肿瘤性甲状腺组织中的表达
Int J Mol Med. 2002 Apr;9(4):373-6.
8
Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.细胞周期蛋白依赖性激酶抑制剂在人前列腺上皮细胞和尿路上皮细胞衰老生长停滞中的作用。
Oncogene. 2001 Dec 13;20(57):8184-92. doi: 10.1038/sj.onc.1205049.
9
Negative regulators of cyclin-dependent kinases and their roles in cancers.细胞周期蛋白依赖性激酶的负调控因子及其在癌症中的作用。
Cell Mol Life Sci. 2001 Nov;58(12-13):1907-22. doi: 10.1007/pl00000826.
10
p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.p16INK4a是切除的导管胰腺癌的一个预后标志物:p16INK4a、p53、MDM2和Rb的分析
Ann Surg. 2002 Jan;235(1):51-9. doi: 10.1097/00000658-200201000-00007.